Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 30090929.
- Also identified by DOI 10.1001/jamasurg.2018.1757 and PMC identifier 6583701.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study assesses the association of immunologic variables and survival in patients with resectable pancreatic ductal adenocarcinoma.
Medical subject headings
- Carcinoma, Pancreatic Ductal
- Pancreatic Neoplasms